Pfizer Is Working on Oral Alternative to Ozempic

Pfizer CEO Albert Bourla says the drug maker is hoping to develop an oral anti-obesity drug that can rival Ozempic. He spoke to David Westin on "Wall Street Week" on Oct. 31 in New York.. -------- Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com Connect with us on... Twitter:   / business   Facebook:   / bloombergbusiness   Instagram:   / bloombergbusiness